Sign in
Taking peopleNo phase

Remote Ischemic Preconditioning in Septic Patients

Key facts

Who runs it
Universität Münster
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
64 people, planned
Started
11 May 2023
Planned end
Jan 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Remote ischemic preconditioning (RIPC)
  • Sham RIPC
Record updated
12 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Adult patients (age ≥18 years)
  • Critically ill patients with sepsis < 12 hours
  • Invasive ventilation for at least 24 hours (propofol-free-sedation) and/or vasopressor therapy
  • Unrestricted intensive care for at least 72 hours
  • Written informed consent

Who cannot take part

  • Kidney transplant in the last 12 months
  • Chronic kidney disease with estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73m²
  • Pre-existing AKI
  • (Glomerulo-)nephritis, interstitial nephritis, vasculitis
  • Chronic dialysis dependency
  • Oral antidiabetics, sulfonamides or nicorandil
  • Pregnancy or breastfeeding
  • Do-not-reanimate order
  • Participation in another interventional trial involving kidney outcomes within the last 3 months
  • Dependency on the investigator or center

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Acute kidney injury is a well-recognized complication in critically ill patients. Up to date there is no clinically established method to reduce the incidence or the severity of acute kidney injury.

Read full original descriptionShow less

Remote ischemic preconditioning (RIPC) will be induced by three cycles of upper limb ischemia.

The aim of the study is to reduce the incidence of AKI by implementing remote ischemic preconditioning (identified by the urinary biomarkers tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7(IGFBP7)

The 2 groups in the trial

  • Intervention GroupTreatment being tested

    Remote ischemic preconditioning (RIPC) Three Cycles of 5-min upper limb ischemia. If there is no response this will be followed by 2 cycles of 10-min upper-limb ischemia.

    Treatment: Remote ischemic preconditioning (RIPC)

  • Control GroupSham treatment, for comparison

    Three cycles of 5- min upper limb sham ischemia.

    Treatment: Sham RIPC

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Remote Ischemic Preconditioning in Septic Patients on Cell Cycle Arrest Biomarkers - the RIPC-ICU Randomized Clinical Trial
Record updated
12 December 2024